Back to search results

WeCan-Rural Program for Breast Cancer Survivors in Rural Communities

This study is testing a program called WeCan-Rural, designed to help breast cancer survivors manage symptoms like pain and fatigue, and build healthy habits around eating, exercise, and weight. These changes may help lower your risk of heart disease after cancer treatment. You may be able to join if you are a woman, 18 or older, have been diagnosed with stage I-III breast cancer, finished most of your cancer treatments in the last 5 years, have a body mass index (BMI) over 30, and are healthy enough for home-based physical activity. The study aims to see if participants find the WeCan-Rural program helpful and easy to follow, and if it leads to better results in weight, symptoms, diet, and physical activity compared to standard care. The current status of this study is unclear.

Study design
This is an interventional study planning to enroll 40 women. It is not specified if it is randomized or blinded.
What's involved
You would participate in 12 weekly, one-hour sessions via Zoom. You would also track your progress using provided tools like an activity tracker, scale, and blood pressure monitor.
Compensation
Not stated in the trial record.
Follow-up
Your satisfaction and acceptability of the program will be measured at about 12-14 weeks after the start of the study.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07426952

Weight Management After Cancer for Survivors in Rural Communities

Recruiting
NAAges 18+InterventionalSupportive care
Duke University
~40 participants
Updated 2026-08-13 on ClinicalTrials.gov
What's tested:WeCan-Rural Program

At a glance

Recruiting sites
5 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Satisfaction with Treatment and Interventionist as measured by the Satisfaction with Therapy and Therapist Scale-Revised (STTS-R)
Measured over Post-treatment (about 12-14 weeks after baseline)
+1 more outcome measured

Conditions

Breast Cancer Survivorship
Weight Management
Cardiovascular (CV) Risk
Breast Cancer

Explore related trials

Breast Carcinoma

Where it's being run

5 sites across 1 states
North Carolina5

Study leadership

  • Caroline Dorfman, PhD · PRINCIPAL_INVESTIGATOR · Duke University

Who to contact

Smrithi Divakaran, MPH
[email protected]
919-681-7695
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

aged 18 years or older
female (biological sex)
diagnosis of stage I-III breast cancer
completed treatments with curative intent (with the exception of hormonal treatments) in the last 5 years
body mass index \>30
healthy enough to participate in home-based physical activity
able to speak/read English
reports rating of ≥4 (i.e., moderate or more severe) out of 10 for one or more of the following symptoms at its worst in the last month (per the MD Anderson Symptom Inventory): pain, fatigue, sadness, and/or distress

Exclusion

visual, hearing or cognitive impairment or severe mental illness interfering with participation

What this trial measures

  • Satisfaction with Treatment and Interventionist as measured by the Satisfaction with Therapy and Therapist Scale-Revised (STTS-R)Post-treatment (about 12-14 weeks after baseline)

    Participants will complete the 13-item Satisfaction with Therapy and Therapist Scale-Revised specific to the program they received. The first 12 items ask participants to rate their agreement with statements related to intervention satisfaction on a 5-point scale ranging from "strongly disagree" (1) to "strongly agree" (5). The 13th item asks "How much did the intervention help with your symptoms?" with 5 answer choices ranging from "made things a lot better" to "made things a lot worse."

  • Acceptability as measured by the Treatment Acceptability QuestionnairePost-treatment (about 12-14 weeks after baseline)

    The Treatment Acceptability Questionnaire is a six-item scale assessing participants' views of an intervention as acceptable, ethical, and effective. Items are rated on a 7-point Likert scale (e.g., 1 "very unacceptable" to 7 "very acceptable") and averaged.